Telehealth brief for Thursday: Proteus, Independa, HemoGlobe, Partners HealthCare
It only took four years, but the Proteus Digital Health (formerly Biomedical) was granted FDA 510(k) premarket approval for the Proteus Ingestible Event Marker (IEM)–the chips in the pills. Both the IEM and the skin sensor patch, which transmits the pill ingestion… Read moreTelehealth brief for Thursday: Proteus, Independa, HemoGlobe, Partners HealthCare
